List of Tables
Table 1. Peripheral T-cell lymphoma Therapy Market Trends
Table 2. Peripheral T-cell lymphoma Therapy Market Drivers & Opportunity
Table 3. Peripheral T-cell lymphoma Therapy Market Challenges
Table 4. Peripheral T-cell lymphoma Therapy Market Restraints
Table 5. Global Peripheral T-cell lymphoma Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Peripheral T-cell lymphoma Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Peripheral T-cell lymphoma Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Peripheral T-cell lymphoma Therapy
Table 10. Global Peripheral T-cell lymphoma Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral T-cell lymphoma Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Peripheral T-cell lymphoma Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Peripheral T-cell lymphoma Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Peripheral T-cell lymphoma Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Peripheral T-cell lymphoma Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Peripheral T-cell lymphoma Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Peripheral T-cell lymphoma Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Peripheral T-cell lymphoma Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Peripheral T-cell lymphoma Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Peripheral T-cell lymphoma Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Peripheral T-cell lymphoma Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Peripheral T-cell lymphoma Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Peripheral T-cell lymphoma Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Peripheral T-cell lymphoma Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Peripheral T-cell lymphoma Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Peripheral T-cell lymphoma Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Peripheral T-cell lymphoma Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Peripheral T-cell lymphoma Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Peripheral T-cell lymphoma Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. Antengene Basic Information List
Table 32. Antengene Description and Business Overview
Table 33. Antengene Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Antengene (2019-2024)
Table 35. Antengene Recent Developments
Table 36. Genor BioPharma Co., Ltd. Basic Information List
Table 37. Genor BioPharma Co., Ltd. Description and Business Overview
Table 38. Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Genor BioPharma Co., Ltd. (2019-2024)
Table 40. Genor BioPharma Co., Ltd. Recent Developments
Table 41. Hospira (Pfizer Inc.) Basic Information List
Table 42. Hospira (Pfizer Inc.) Description and Business Overview
Table 43. Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Hospira (Pfizer Inc.) (2019-2024)
Table 45. Hospira (Pfizer Inc.) Recent Developments
Table 46. Dizal Pharma Basic Information List
Table 47. Dizal Pharma Description and Business Overview
Table 48. Dizal Pharma Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Dizal Pharma (2019-2024)
Table 50. Dizal Pharma Recent Developments
Table 51. Bristol-Myers Squibb Company Basic Information List
Table 52. Bristol-Myers Squibb Company Description and Business Overview
Table 53. Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Bristol-Myers Squibb Company (2019-2024)
Table 55. Bristol-Myers Squibb Company Recent Developments
Table 56. Sigma-Tau Pharmaceuticals, Inc. Basic Information List
Table 57. Sigma-Tau Pharmaceuticals, Inc. Description and Business Overview
Table 58. Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Sigma-Tau Pharmaceuticals, Inc. (2019-2024)
Table 60. Sigma-Tau Pharmaceuticals, Inc. Recent Developments
Table 61. Pacira Pharmaceuticals, Inc. Basic Information List
Table 62. Pacira Pharmaceuticals, Inc. Description and Business Overview
Table 63. Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Pacira Pharmaceuticals, Inc. (2019-2024)
Table 65. Pacira Pharmaceuticals, Inc. Recent Developments
Table 66. Spectrum Pharmaceuticals, Inc. Basic Information List
Table 67. Spectrum Pharmaceuticals, Inc. Description and Business Overview
Table 68. Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Spectrum Pharmaceuticals, Inc. (2019-2024)
Table 70. Spectrum Pharmaceuticals, Inc. Recent Developments
Table 71. Celgene Corporation Basic Information List
Table 72. Celgene Corporation Description and Business Overview
Table 73. Celgene Corporation Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Celgene Corporation (2019-2024)
Table 75. Celgene Corporation Recent Developments
Table 76. Eisai Co., Ltd. Basic Information List
Table 77. Eisai Co., Ltd. Description and Business Overview
Table 78. Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Eisai Co., Ltd. (2019-2024)
Table 80. Eisai Co., Ltd. Recent Developments
Table 81. Leadiant Biosciences Basic Information List
Table 82. Leadiant Biosciences Description and Business Overview
Table 83. Leadiant Biosciences Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 84. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Leadiant Biosciences (2019-2024)
Table 85. Leadiant Biosciences Recent Developments
Table 86. Merck Basic Information List
Table 87. Merck Description and Business Overview
Table 88. Merck Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 89. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Merck (2019-2024)
Table 90. Merck Recent Developments
Table 91. Genmab AS Basic Information List
Table 92. Genmab AS Description and Business Overview
Table 93. Genmab AS Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 94. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of Genmab AS (2019-2024)
Table 95. Genmab AS Recent Developments
Table 96. HUYABIO International Basic Information List
Table 97. HUYABIO International Description and Business Overview
Table 98. HUYABIO International Peripheral T-cell lymphoma Therapy Products, Services and Solutions
Table 99. Revenue (US$ Million) in Peripheral T-cell lymphoma Therapy Business of HUYABIO International (2019-2024)
Table 100. HUYABIO International Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Peripheral T-cell lymphoma Therapy Downstream Customers
Table 104. Peripheral T-cell lymphoma Therapy Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Peripheral T-cell lymphoma Therapy Product Picture
Figure 2. Global Peripheral T-cell lymphoma Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Peripheral T-cell lymphoma Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Peripheral T-cell lymphoma Therapy Report Years Considered
Figure 5. Global Peripheral T-cell lymphoma Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Peripheral T-cell lymphoma Therapy Revenue in 2023
Figure 7. Peripheral T-cell lymphoma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Chidamide Picture
Figure 9. Selinexor Picture
Figure 10. Other Picture
Figure 11. Global Peripheral T-cell lymphoma Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Peripheral T-cell lymphoma Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Clinics
Figure 15. Global Peripheral T-cell lymphoma Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Peripheral T-cell lymphoma Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Peripheral T-cell lymphoma Therapy Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Peripheral T-cell lymphoma Therapy Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Peripheral T-cell lymphoma Therapy Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Peripheral T-cell lymphoma Therapy Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Peripheral T-cell lymphoma Therapy Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Peripheral T-cell lymphoma Therapy Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Peripheral T-cell lymphoma Therapy Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Peripheral T-cell lymphoma Therapy Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Peripheral T-cell lymphoma Therapy Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Peripheral T-cell lymphoma Therapy Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Peripheral T-cell lymphoma Therapy Sales Value (%), (2019-2030)
Figure 28. United States Peripheral T-cell lymphoma Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Peripheral T-cell lymphoma Therapy Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Peripheral T-cell lymphoma Therapy Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Peripheral T-cell lymphoma Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Peripheral T-cell lymphoma Therapy Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Peripheral T-cell lymphoma Therapy Sales Value by Application (%), 2023 VS 2030
Figure 34. China Peripheral T-cell lymphoma Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Peripheral T-cell lymphoma Therapy Sales Value by Type (%), 2023 VS 2030
Figure 36. China Peripheral T-cell lymphoma Therapy Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Peripheral T-cell lymphoma Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Peripheral T-cell lymphoma Therapy Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Peripheral T-cell lymphoma Therapy Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Peripheral T-cell lymphoma Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Peripheral T-cell lymphoma Therapy Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Peripheral T-cell lymphoma Therapy Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Peripheral T-cell lymphoma Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Peripheral T-cell lymphoma Therapy Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Peripheral T-cell lymphoma Therapy Sales Value by Application (%), 2023 VS 2030
Figure 46. India Peripheral T-cell lymphoma Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Peripheral T-cell lymphoma Therapy Sales Value by Type (%), 2023 VS 2030
Figure 48. India Peripheral T-cell lymphoma Therapy Sales Value by Application (%), 2023 VS 2030
Figure 49. Peripheral T-cell lymphoma Therapy Industrial Chain
Figure 50. Peripheral T-cell lymphoma Therapy Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
